HEALTH ADVANCE INC. Inactive Instrument
Health Advance Inc. Share Price Other OTC
Equities
HADV
US42225L2034
Biotechnology & Medical Research
| Sales 2015 | - | Sales 2016 | - | Capitalization | 1.23M 97.96M |
|---|---|---|---|---|---|
| Net income 2015 | - 0 | Net income 2016 | - 0 | EV / Sales 2015 | - |
| Net Debt 2015 | 72.77K 5.81M | Net Debt 2016 | 98.54K 7.87M | EV / Sales 2016 | - |
| P/E ratio 2015 |
-39.9
x | P/E ratio 2016 |
-41.6
x | Employees | - |
| Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 39.05% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Larry McLachlin
CEO | Chief Executive Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Larry McLachlin
CEO | Chief Executive Officer | - | - |
Health Advance, Inc. is focused on cannabidiol (CBD) infused dealcoholized wine beverage products and a new nutraceutical product range. Its principal products or services include CBD infused dealcoholized wine and immune boosting nutraceutical in pre-production. The Companyâs subsidiary is Courtship Wines, Inc.
| 1st Jan change | Capi. | |
|---|---|---|
| +0.67% | 42.4B | |
| +46.73% | 40.04B | |
| -6.20% | 28.31B | |
| +6.55% | 24.94B | |
| -21.66% | 18.96B | |
| +29.96% | 12.3B | |
| -1.57% | 11.95B | |
| +16.03% | 11.32B | |
| -4.80% | 11.55B |
